Marc Beer is the CEO, Co-Founder and Chairman of Renovia Inc. Company. The medtech company which is based in Boston seeks to develop therapeutic and diagnostic devices that treat disorders of the pelvic floor, such as urinary incontinence. Such conditions have been found to affect over 250 million women from all over the world. Mr. Marc Beer raised $42M recently as fund for women’s health. Leva, which was the company’s first product received a FDA approval in April. The funding that was given by Mr. Beer was to be channeled towards testing and developing some four other diagnostic and therapeutic products. Also included in the latter is a new generation product of Leva.
Mr. Marc Beer’s Past Experience and Achievements
Marc Beer has 25 years and over, of commercialization experience and development in pharmaceuticals, diagnostics, biotechnology and devices. Mr. Beer founded Renovia in 2016 together the Managing Director, Ramon Iglesias and Yolanda Lorie. The trio successfully established a health care venture with leading capital funds.
Marc Beer became the founding CEO of a biotechnology company called ViaCell (NASDAQ: VIAC), which specialized in the collection, development and preservation of umbilical cord stem blood cells. He successfully led this organization from its inception; for seven years, and turned it into a robust and rapidly growing commercial organization. The company was able to grow to more than 300 employees under Marc’s able leadership. In 2005, the company was taken in as a public entity which was then ultimately acquired by Perkin Elmer in 2007.
Marc was also a member of the board of Directors of Erytech Pharma (NASDAQ: ERYP), which is a biopharmaceutical company that is publicly traded. Mr. Beer held this particular position while he was still a CEO of ViaCell. Before becoming a CEO to ViaCell, Marc served in several positions within Genzyme. For instance, he was the Vice President of the Global Marketing whereby he presided over the launch of many products that addressed rare population diseases all over the world.
Marc Beer also held several sales and marketing positions in the diagnostic and pharmaceutical departments of Abbott Laboratories. He also served in the Board of the Commonwealth in Massachusetts as a member of the Mass Life Science Board. Additionally, he served in the Company Governing Board of the Biotechnology Industry Organization.
He was the Founding Chairman of the committee and the board of Directors of compensation of Good Start Genetics Inc. This committee however, recently got acquired by InVitae. Marc also serves in Minerva Neurosciences Inc. as the chairman of the compensation committee, Founding Chairman of the board and a member of the audit committee. He also is a member of the Miami University Business Advisory Council.
- Marc Beer has a vast experience in his area of expertise. He has over 25 years’ experience in commercialization and development in pharmaceuticals, biotechnology and diagnostics. As the CEO, Co-founder and Chairman of the Renovia Inc. Company therefore; he works to fund the facility in order to help women with pelvic floor disorders. Learn more: https://www.slideshare.net/MarcBeer